Today Carl Icahn released the following statement regarding Cigna Corporation: In light of the ISS and Glass Lewis recommendations in favor of the Cigna (CI) / Express Scripts (ESRX) transaction and the significant stockholder overlap between the two companies, we have informed the SEC that we no longer intend to solicit proxies to vote against the transaction.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.